Johnson & Johnson
- SEC CIK
- 0000200406
- Latest filing
- Aug 6, 2026
GYRE holding history
Gyre Therapeutics, Inc. in every 13F filed by Johnson & Johnson, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
GYRE overviewAll 13F holders of GYREFull Q2 2026 holdings
- Shares (Q4 2023)
- 0
- Sold out in Q4 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2023 | 0 | $0 | 0.0% | −66,951−100.0% | Sold out | Holders |
| Q3 2023 | 66,951 | $32.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 66,951 | $23.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 66,951 | $13.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 66,951 | $35.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 66,951 | $34.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 66,951 | $119.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 66,951 | $44.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 66,951 | $61.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 66,951 | $275.0K | <0.1% | – | No prior filing | Holders |